BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Solitano V, Vuitton L, Peyrin-Biroulet L, Danese S. The Evolution of Biologics Administration From Intravenous to Subcutaneous: Treatments for Inflammatory Bowel Disease Go Home. Gastroenterology 2021;160:2244-7. [PMID: 33773995 DOI: 10.1053/j.gastro.2021.03.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Alten R, An Y, Kim DH, Yoon S, Peyrin-Biroulet L. Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit. Clin Drug Investig 2022;42:477-89. [PMID: 35657560 DOI: 10.1007/s40261-022-01162-6] [Reference Citation Analysis]
2 Schreiber S, Ben-Horin S, Alten R, Westhovens R, Peyrin-Biroulet L, Danese S, Hibi T, Takeuchi K, Magro F, An Y, Kim DH, Yoon S, Reinisch W. Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era. Adv Ther 2022;39:2342-64. [PMID: 34988877 DOI: 10.1007/s12325-021-01990-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Patil SA, Bhat S, Limdi JK, Farraye FA, Cross RK. The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac048. [PMID: 35353189 DOI: 10.1093/ibd/izac048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Czaja AJ. Advancing Biologic Therapy for Refractory Autoimmune Hepatitis. Dig Dis Sci 2022. [PMID: 35147819 DOI: 10.1007/s10620-021-07378-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Solitano V, Parigi TL, Ragaini E, Danese S. Anti-integrin drugs in clinical trials for inflammatory bowel disease (IBD): insights into promising agents. Expert Opin Investig Drugs 2021;30:1037-46. [PMID: 34449288 DOI: 10.1080/13543784.2021.1974396] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Solitano V, Alfarone L, D'Amico F, Peyrin-Biroulet L, Danese S. IBD goes home: from telemedicine to self-administered advanced therapies. Expert Opin Biol Ther 2021;:1-13. [PMID: 34116611 DOI: 10.1080/14712598.2021.1942833] [Reference Citation Analysis]